Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-31611353

RESUMO

The use of the Sensititre YeastOne YO10 alamarBlue assay for the in vitro susceptibility testing of Madurella mycetomatis was evaluated in M. mycetomatis isolates with and without pyomelanin secretion. Pyomelanin secretion did not influence visual endpoint reading; however, it caused a shift in peak absorbance from 570 nm to 620 nm when read spectrophotometrically. Therefore, when choosing the method for endpoint reading, the presence of pyomelanin should be considered.


Assuntos
Madurella/metabolismo , Melaninas/metabolismo , Micetoma/metabolismo , Azóis/metabolismo , Madurella/genética , Melaninas/genética
2.
J Eur Acad Dermatol Venereol ; 29(10): 1873-83, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25726758

RESUMO

Mycetoma is a chronic putrid infection of the cutaneous and subcutaneous tissue concerning predominantly the feet, and more rarely other body parts. Mycetoma can be caused by both fungi (eumycetoma) and bacteria (actinomycetoma). Mode of infection is an inoculation of the causative microorganism via small injuries of the skin. The clinical correlate of both forms of mycetoma is tumescence with abscesses, painless nodules, sinuses and discharge. The latter is commonly serous-purulent and contains grains (filamentous granules) which can be expressed for diagnostic purposes. Distinctive for both eumycetoma and actinomycetoma, are the formation of grains. Grains represent microcolonies of the microorganism in vivo in the vital tissue. The most successful treatment option for eumycetomas offers itraconazole in a dosage of 200 mg twice daily. This triazole antifungal is considered as 'gold standard' for eumycetomas. Alternatively, the cheaper ketoconazole was widely used, however, it was currently stopped by the FDA. Actinomycetomas should be treated by the combination of trimethoprim-sulphamethoxazole (co-trimoxazole 80/400 to 160/800 mg per day) and amikacin 15 mg/kg body weight per day. Mycetomas are neglected infections of the poor. They are more than a medical challenge. In rural areas of Africa, Asia and South America mycetomas lead to socio-economic consequences involving the affected patients, their families and the society in general.


Assuntos
Infecções por Actinomycetales/complicações , Actinomycetales , Antifúngicos/uso terapêutico , Madurella , Micetoma/diagnóstico , Micetoma/microbiologia , Amputação Cirúrgica , Animais , Antibacterianos/uso terapêutico , Citocinas/metabolismo , Desbridamento , Diagnóstico Diferencial , Humanos , Inflamação/metabolismo , Inflamação/microbiologia , Itraconazol/uso terapêutico , Micetoma/epidemiologia , Micetoma/metabolismo , Micetoma/terapia , Naftalenos/uso terapêutico , Terbinafina , Triazóis/uso terapêutico
3.
Indian J Ophthalmol ; 55(3): 226-7, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17456946

RESUMO

Endogenous intraocular infection of fungal etiology is extremely rare in an immunocompetent individual. Usually, an antecedent history of trauma, surgery, intravenous drug abuse or an immunocompromized state can be elicited. Scedosporium apiospermum is a known cause of keratomycosis after traumatic implantation and can cause fatal disseminated infection in immunocompromized patients. However, cases of S. apiospermum intraocular infection in immunocompetent individuals have been very rarely reported in literature. We report here a case of an anterior chamber exudative mass due to S. apiospermum in an immunocompetent individual which was managed successfully with anterior chamber wash and intravitreal injection of voriconazole.


Assuntos
Câmara Anterior/metabolismo , Exsudatos e Transudatos/metabolismo , Infecções Oculares Fúngicas/metabolismo , Imunocompetência , Micetoma/metabolismo , Scedosporium , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Olho , Infecções Oculares Fúngicas/tratamento farmacológico , Infecções Oculares Fúngicas/patologia , Humanos , Injeções , Masculino , Pessoa de Meia-Idade , Micetoma/tratamento farmacológico , Micetoma/patologia , Pirimidinas/administração & dosagem , Pirimidinas/uso terapêutico , Triazóis/administração & dosagem , Triazóis/uso terapêutico , Corpo Vítreo , Voriconazol
4.
Res Microbiol ; 157(5): 425-32, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16487686

RESUMO

Pseudallescheria boydii is an opportunistic filamentous fungus that causes serious infections in humans. Virulence attributes expressed by P. boydii are unknown. Conversely, peptidases are incriminated as virulence factors in several pathogenic fungi. Here we investigated the extracellular peptidase profile in P. boydii. After growth on Sabouraud for 7 days, mycelia of P. boydii were incubated for 20 h in PBS-glucose. The cell-free PBS-glucose supernatant was submitted to SDS-PAGE and 12 secretory polypeptides were observed. Two of these polypeptides (28 and 35 kD) presented proteolytic activity when BSA was used as a copolymerized substrate. The extracellular peptidases were most active in acidic pH (5.5) and fully inhibited by 1,10-phenanthroline, a zinc-metallopeptidase inhibitor. Other metallo-, cysteine, serine and aspartic proteolytic inhibitors did not significantly alter these activities. To confirm that these enzymes belong to the metallo-type peptidases, the apoenzymes were obtained by dialysis against chelating agents, and supplementation with different cations, especially Cu(2+) and Zn(2+), restored their activities. Except for gelatin, both metallopeptidases hydrolyzed various co-polymerized substrates, including human serum albumin, casein, hemoglobin and IgG. Additionally, the metallopeptidases were able to cleave different soluble proteinaceous substrates such as extracellular matrix components and sialylated proteins. All these hydrolyses were inhibited by 1,10-phenanthroline. Interestingly, Scedosporium apiospermum (the anamorph of P. boydii) produced a distinct extracellular peptidase profile. Collectively, our results demonstrated for the first time the expression of acidic extracellular metallopeptidases in P. boydii capable of degrading several proteinaceous compounds that could help the fungus to escape from natural human barriers and defenses.


Assuntos
Proteínas Fúngicas/metabolismo , Metaloproteases/metabolismo , Peptídeos/metabolismo , Proteínas/metabolismo , Pseudallescheria/metabolismo , Caseínas/metabolismo , Proteínas Fúngicas/antagonistas & inibidores , Proteínas Fúngicas/biossíntese , Proteínas Fúngicas/química , Hemoglobinas/metabolismo , Humanos , Imunoglobulina G/metabolismo , Metaloproteases/antagonistas & inibidores , Metaloproteases/biossíntese , Metaloproteases/química , Peso Molecular , Micetoma/metabolismo , Micetoma/microbiologia , Biossíntese Peptídica , Peptídeos/antagonistas & inibidores , Peptídeos/química , Fenantrolinas/farmacologia , Scedosporium/metabolismo , Albumina Sérica/metabolismo
5.
Br J Dermatol ; 97(5): 497-9, 1977 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-588463

RESUMO

The tissue grain of Madurella mycetomi infection shows a spread of mineral constituents which is somewhat higher than the known values for the dermis, but differs little in relative concentrations. The unique physical resistance of the grain cannot be related to departures in concentration of calcium or of trace elements. Our earlier hypothesis of a tanned protein structure for the grain therefore still holds (Findlay & Vismer, 1974).


Assuntos
Micetoma/metabolismo , Pele/análise , Humanos , Espectrometria de Massas , Minerais/análise , Espectrofotometria Atômica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...